---
category: news
title: "Lantern and Deep Lens partner to expedite Phase II NSCLC trial enrolment"
excerpt: "Lantern Pharma has signed a strategic partnership with Deep Lens to accelerate enrolment in the formerâ€™s Phase II clinical trial of LP-300 plus chemotherapy to treat never-smokers with non-small cell lung cancer (NSCLC)."
publishedDateTime: 2021-09-29T10:54:00Z
originalUrl: "https://www.clinicaltrialsarena.com/news/lantern-deep-lens-partner-to-speed-up-phase-ii-nsclc-trial-enrolment/"
webUrl: "https://www.clinicaltrialsarena.com/news/lantern-deep-lens-partner-to-speed-up-phase-ii-nsclc-trial-enrolment/"
type: article
quality: 23
heat: 23
published: false

provider:
  name: Clinical Trials Arena
  domain: clinicaltrialsarena.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://www.clinicaltrialsarena.com/wp-content/uploads/sites/33/2021/09/Lantern.jpg"
    width: 1920
    height: 1280
    isCached: true

secured: "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;1MdyjCtdpL5qlvkuVCXgkw=="
---

